Bill in Congress Targets PFAS, Phthalates, BPA in Food Packaging

Why It Matters

The bill could dramatically reduce consumer exposure to carcinogens and endocrine disruptors, reshaping the food‑packaging supply chain and setting a federal standard that aligns with state‑level health protections.

Key Takeaways

• Bill bans 17 chemicals from food-contact materials.
• Does not pre‑empt state-level PFAS packaging bans.
• Sponsored by Blumenthal, Schakowsky, De Lauro; nearly a dozen co‑sponsors.
• FDA evaluating cumulative risk of eight phthalates for future action.
• Consumer groups flag eight known and 17 probable carcinogens allowed.

Pulse Analysis

Public awareness of chemicals like PFAS, phthalates, and BPA has surged after documentaries and scientific reports linked them to cancer, hormone disruption, and infertility. Consumers increasingly demand transparency, prompting advocacy groups to pressure lawmakers and regulators. The No Toxics in Food Packaging Act reflects this shift, targeting a broad list of substances that the FDA currently permits, and underscores a growing consensus that food‑contact safety must evolve beyond legacy approvals.

The legislative effort builds on a patchwork of state actions; Illinois and Maine have already enacted bans on PFAS in food packaging, setting precedents for stricter standards. By deliberately not pre‑empting state regulations, the bill respects regional initiatives while providing a federal framework that could harmonize compliance across the industry. Backed by the Environmental Defense Fund, Consumer Reports, and other NGOs, the bill enjoys bipartisan concern for public health, though the American Chemistry Council warns of potential supply‑chain disruptions and cost implications.

Regulatory momentum is evident as the FDA recently released a scientific evaluation of eight phthalates used in food‑contact plastics, hinting at a future cumulative risk assessment. If the bill passes, manufacturers will need to reformulate packaging, accelerating investment in safer alternatives such as bio‑based polymers and inert barrier films. This transition could create new market opportunities for innovators while compelling legacy producers to adapt or face fragmented state enforcement. Ultimately, the act aims to align federal policy with emerging scientific consensus, reducing toxic exposure and fostering a healthier food ecosystem.